CHICAGO, November 2, 2016 /PRNewswire/ --
According to the new market research report, "Heparin Market, by Product (Unfractionated Heparin, Low Molecular Weight Heparin(LMWH), Ultra Lower Molecular Weight Heparin(ULMWH)), Route of Administration (IV Injection, Subcutaneous Injection), Applications (Clinical Trials, Medical Devices, Venous Thromboembolism) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022", published by Scalar Market Research, the heparin market will grow at a steady CAGR of 5.07% and reach from USD 7.58 billion in 2016 to USD 10.20 billion by 2022.
The global heparin market report offers in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key players, premium trends and forecast to 2022. It also focuses on the key drivers and opportunities in this market.
Browse Report Summary: https://www.scalarmarketresearch.com/market-reports/heparin-market
Buyers can expect to receive 100% customization on this report.
Key findings of the report:
- Rising instances of venous thromboembolism (VTE) and obesity amongst the global population are expected to drive the demand for the heparin market around the world.
- Growth in the adoption of anticoagulants and declining imports from China are also expected to drive the overall demand in the global market. Possibilities of the rise in demand for bovine heparin and synthetic heparin are expected to drive the market, especially across North America.
- Growth in the adoption of anticoagulants and declining imports from China are also expected to drive the overall demand in the global market.
Ultra-Low Molecular Weight Heparin (ULMWH) is expected to dominate the product segment
According to the report, the ultra-low molecular weight heparin is expected to witness the fastest growth in the heparin market, during the forecast period. the report attributes this strong growth of this segment to the growth in the instances of different types of cancer and the growing number of patients opting for chemotherapy. The report expects North America to hold the largest share of the heparin market during the forecast period.
Request Sample: https://www.scalarmarketresearch.com/request-sample.php?id=120
The report includes information about some of the key players in the heparin market, which include:
- Leo Pharma
- Baxter Healthcare
- Fresnius Kabi AG
- Aspen Holdings
Browse Related Reports:
Medical Robotics Market, by Application (Neurology, Laparoscopy, Cardiology, Orthopedic, Special Education), Product (Robotic Systems, Instruments & Accessories) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022
Synthetic Biology Market, by Product (Core Products and Enabling Products), Application (Chemical, Healthcare and Agriculture), Technology (Genome Engineering, DNA Sequencing, Bioinformatics and Biological Components and Integration Systems) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022
About Scalar Market Research
Scalar Market Research, Inc. is a Chicago, U.S.-based market research and consulting firm that serves Fortune 1000 companies, leading businesses and upcoming organizations from around the world to help them achieve their business goal of sustainable revenue growth, utilizing Scalar's premium market research reports and consulting services to make critical strategic decisions.
Our real-time industry data tracking, with the help of advanced analytics and machine learning, offers our clients highly accurate 360-degree perspective of key developments in niche markets. Our team of industry experts, with a thorough understanding of global markets and cumulative industry experience spanning 100+ years, work relentlessly to help our clients realize their most important business goals.
Find out more about our services at: www.scalarmarketresearch.com
Mr. Rahul Ganju
8770 W Bryn Mawr Ave.,
Chicago, IL 60631
Tel.: +1-800-213-5170 (U.S./Canada Toll-free)
Follow us on LinkedIn: https://www.linkedin.com/company/scalar-market-research
SOURCE Scalar Market Research